Clinical Trials List
2012-07-01 - 2015-07-31
Phase II
Terminated4
-
Trial Applicant
Merck Sharp & Dohme (I.A.) LLC
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- Chun-Yu Liu Division of General Surgery
- Yi-Fang Tsai Division of General Surgery
- Ta-Chung Chao Division of General Surgery
- 金光亮 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- TSU-YI CHAO Division of Hematology & Oncology
- 陳宇欽 Division of Hematology & Oncology
- 張平潁 Division of Hematology & Oncology
- 何景良 Division of Hematology & Oncology
- 高偉堯 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 林鉷彬 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
4~8 participants
-
Global
150 participants
